Neuroblastoma Interaction with the Tumour Microenvironment and Its Implications for Treatment and Disease Progression

Curr Oncol. 2023 Oct 15;30(10):9116-9140. doi: 10.3390/curroncol30100659.

Abstract

Neuroblastoma, a paediatric malignancy of the peripheral nervous system, displays a wide range of clinical outcomes, including regression to fatality despite extensive treatment. Neuroblastoma tumours display a complex interplay with their surrounding environment, known as the tumour microenvironment, which may affect disease progression and patient prognosis. This study aimed to dissect the ways in which neuroblastoma biology, treatment, prognosis, progression, and relapse are linked with the extracellular matrix, the dichotomous identities of neuroblastoma, various regulatory proteins and RNA, and extracellular vesicles within the backdrop of the tumour microenvironment. In addition, other aspects, such as immune cell infiltration, therapeutic options including monoclonal antibodies and small molecule inhibitors; and the ways in which these may affect disease progression and immunosuppression within the context of the neuroblastoma tumour microenvironment, are addressed. Such studies may shed light on useful therapeutic targets within the tumour microenvironment that may benefit groups of NB patients. Ultimately, a detailed understanding of these aspects will enable the neuroblastoma scientific community to improve treatment options, patient outcomes, and quality of life.

Keywords: disease progression; neuroblastoma; treatment; tumour microenvironment.

Publication types

  • Review

MeSH terms

  • Child
  • Disease Progression
  • Humans
  • Neoplasm Recurrence, Local
  • Neuroblastoma* / genetics
  • Neuroblastoma* / metabolism
  • Neuroblastoma* / therapy
  • Quality of Life
  • Tumor Microenvironment* / genetics

Grants and funding

This research received no external funding.